DB
RPTP

Dmitry Balyasny’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Dmitry Balyasny’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100,000
Closed -$605K – 1667
2015
Q3 		$605K Buy
+100,000
New +$1.23M ﹤0.01% 792

Other funds holding RPTP

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.96% 1-Year Est. Return

Dmitry Balyasny's RPTP Position: Q3 2016 in Review

Dmitry Balyasny sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 338,620 shares — an estimated $1.82M sold.

Dmitry Balyasny first reported a position in RPTP in Q3 2015 and held it in 4 quarters. The position peaked at $7.3M in Q4 2015. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Dmitry Balyasny reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Dmitry Balyasny sold 338,620 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $1.82M.
  • Dmitry Balyasny first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2015 and held it in 4 quarters.
  • Dmitry Balyasny's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $7.3M in Q4 2015.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Balyasny Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.